A E Warren Selected Research

IMP Dehydrogenase

7/2001	Targeting of human Tmolt4 leukemic type II IMP dehydrogenase by cyclic imide related derivatives.
4/2001	Tmolt4 leukemic type II isoform of IMP dehydrogenase as a target for 1,2,4-triazolidine-3,5-diones, 1-(1-(3-methylphenyl)ethylidineamino)-4,4-diethyl-3,5-azetidinediones, 3,5-isoxazolidinediones, and 4,4-disubstituted-3,5-pyrazolidinediones.
1/2001	The cytotoxicity of 1-(1-phenylalkylideneamino)-2,4-azetidinediones and their mode of action in human and murine tumor cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

A E Warren Research Topics

Disease

2	T-Cell Leukemia (Leukemia, T Cell) 07/2001 - 01/2000
2	Leukemia 04/2001 - 01/2001
2	Neoplasms (Cancer) 01/2001 - 01/2000
1	Adenocarcinoma 01/2001
1	Lymphoid Leukemia 01/2001
1	Lymphoma (Lymphomas) 01/2001
1	Osteosarcoma (Osteogenic Sarcoma) 01/2001
1	Carcinoma (Carcinomatosis) 01/2001

Drug/Important Bio-Agent (IBA)

3	IMP DehydrogenaseIBA 07/2001 - 01/2001
3	DNA (Deoxyribonucleic Acid)IBA 04/2001 - 01/2000
2	EnzymesIBA 04/2001 - 01/2001
2	purineIBA 04/2001 - 01/2001
2	RNA (Ribonucleic Acid)IBA 01/2001 - 01/2000
1	AzepinesIBA 07/2001
1	Protein Isoforms (Isoforms)IBA 04/2001
1	Cytotoxins (Cytolysins)IBA 01/2001
1	TransferasesIBA 01/2001
1	PyrrolesIBA 01/2000